SYMBRAVO
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
81968-020 -
Package NDC
81968-020-02 -
Package NDC
81968-020-03 -
Package NDC
81968-020-09 -
Application number
NDA215431 -
SPL ID
2d0cbcfb-3201-4bc3-84e2-b6692fc218a0 -
SPL set ID
dcf1ecd1-08a0-8e47-e053-2a95a90abdc7 -
UNII
VG2QF83CGL -
UNII
WR978S7QHH -
RxCUI
2711789 -
RxCUI
2711795
What the source publishes
- Labeler
- Axsome Therapeutics, Inc.
- Active ingredients
- meloxicam, rizatriptan
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "SYMBRAVO",
"splId": "2d0cbcfb-3201-4bc3-84e2-b6692fc218a0",
"labels": [
{
"setId": "dcf1ecd1-08a0-8e47-e053-2a95a90abdc7",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dcf1ecd1-08a0-8e47-e053-2a95a90abdc7",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=dcf1ecd1-08a0-8e47-e053-2a95a90abdc7"
}
],
"routes": [
"ORAL"
],
"labeler": "Axsome Therapeutics, Inc.",
"finished": true,
"packaging": [
{
"sample": true,
"description": "1 BOTTLE in 1 CARTON (81968-020-02) / 2 TABLET in 1 BOTTLE",
"package_ndc": "81968-020-02",
"identifierStatus": "well-formed",
"marketing_start_date": "20251121"
},
{
"sample": true,
"description": "1 BOTTLE in 1 CARTON (81968-020-03) / 3 TABLET in 1 BOTTLE",
"package_ndc": "81968-020-03",
"identifierStatus": "well-formed",
"marketing_start_date": "20250519"
},
{
"sample": false,
"description": "9 TABLET in 1 BOTTLE (81968-020-09)",
"package_ndc": "81968-020-09",
"identifierStatus": "well-formed",
"marketing_start_date": "20250519"
}
],
"productId": "81968-020_2d0cbcfb-3201-4bc3-84e2-b6692fc218a0",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "81968-020",
"deaSchedule": null,
"genericName": "meloxicam, rizatriptan",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "MELOXICAM",
"strength": "20 mg/1"
},
{
"name": "RIZATRIPTAN BENZOATE",
"strength": "10 mg/1"
}
],
"applicationNumber": "NDA215431",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20250519",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000000160",
"M0001335",
"N0000175722"
],
"upc": [
"0381968020034",
"0381968020096"
],
"unii": [
"VG2QF83CGL",
"WR978S7QHH"
],
"rxcui": [
"2711789",
"2711795"
],
"spl_set_id": [
"dcf1ecd1-08a0-8e47-e053-2a95a90abdc7"
],
"pharm_class_cs": [
"Anti-Inflammatory Agents, Non-Steroidal [CS]"
],
"pharm_class_epc": [
"Nonsteroidal Anti-inflammatory Drug [EPC]"
],
"pharm_class_moa": [
"Cyclooxygenase Inhibitors [MoA]"
],
"manufacturer_name": [
"Axsome Therapeutics, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:81968-020_2d0cbcfb-3201-4bc3-84e2-b6692fc218a0"